DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ACHN-975
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACHN-975
×
Maximum Phase:
1
First Approval:
None
UNII:
48CET2EN53
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O4
Molecular Weight:
369.42
AlogP:
0.01
PSA:
124.68
HBD:
5.0
HBA:
#RotB:
5.0
Source:
SC-006
1
Unknown
Investigational
Unknown
Unknown
Colorectal Neoplasms
Unknown
SC-006
×
Maximum Phase:
1
First Approval:
None
UNII:
293BGU7HL8
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FGF-1 141
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FGF-1 141
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORILANOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Anemia, Hemolytic, Autoimmune
Unknown
ORILANOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
1LTT6HMX9N
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FENAMIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Unknown
FENAMIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
952VN06WBB
Molecule Type:
Small molecule
Molecular Formula:
C13H11NO2
Molecular Weight:
213.24
AlogP:
3.13
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PAC-1
1
Small molecule
Investigational
Unknown
Unknown
Astrocytoma; Glioblastoma; Neuroendocrine Tumors
Unknown
PAC-1
×
Maximum Phase:
1
First Approval:
None
UNII:
9LIS8N0B2C
Molecule Type:
Small molecule
Molecular Formula:
C23H28N4O2
Molecular Weight:
392.5
AlogP:
2.39
PSA:
68.17
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TAK-733
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
TAK-733
×
Maximum Phase:
1
First Approval:
None
UNII:
5J61HSP0QJ
Molecule Type:
Small molecule
Molecular Formula:
C17H15F2IN4O4
Molecular Weight:
504.23
AlogP:
1.07
PSA:
109.38
HBD:
3.0
HBA:
#RotB:
5.0
Source:
LS 11
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LS 11
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MOSUNETUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular
B-lymphocyte antigen CD20 binding agent
MOSUNETUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
LDJ89SS0YG
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
QC-12
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
QC-12
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
2'-F-ARA-DEOXYURIDINE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
2'-F-ARA-DEOXYURIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ALTIRATINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
ALTIRATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
T678746713
Molecule Type:
Small molecule
Molecular Formula:
C26H21F3N4O4
Molecular Weight:
510.47
AlogP:
5.0
PSA:
109.42
HBD:
3.0
HBA:
#RotB:
8.0
Source:
PF-00562271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Focal adhesion kinase 1 inhibitor
PF-00562271
×
Maximum Phase:
1
First Approval:
None
UNII:
K5BX8ZA7UF
Molecule Type:
Small molecule
Molecular Formula:
C21H20F3N7O3S
Molecular Weight:
507.5
AlogP:
3.14
PSA:
129.21
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DS-1062A
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DS-1062A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-1390
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
AZD-1390
×
Maximum Phase:
1
First Approval:
None
UNII:
CI43QFE22O
Molecule Type:
Small molecule
Molecular Formula:
C27H32FN5O2
Molecular Weight:
477.58
AlogP:
4.93
PSA:
65.18
HBD:
0.0
HBA:
#RotB:
7.0
Source:
PHI-101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
PHI-101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H19FN4O2S
Molecular Weight:
386.45
AlogP:
2.26
PSA:
96.25
HBD:
4.0
HBA:
#RotB:
3.0
Source:
TELINAVIR
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
HIV-1 protease inhibitor
TELINAVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
IZF55EH3CG
Molecule Type:
Small molecule
Molecular Formula:
C33H44N6O5
Molecular Weight:
604.75
AlogP:
2.76
PSA:
166.75
HBD:
5.0
HBA:
#RotB:
13.0
Source:
ALT-801
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Melanoma; Multiple Myeloma; Neoplasms; Non-alcoholic Fatty Liver Disease; Urinary Bladder Neoplasms
Unknown
ALT-801
×
Maximum Phase:
1
First Approval:
None
UNII:
QWZ40O5W6K
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-9496
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
AZD-9496
×
Maximum Phase:
1
First Approval:
None
UNII:
DA9P7LN909
Molecule Type:
Small molecule
Molecular Formula:
C25H25F3N2O2
Molecular Weight:
442.48
AlogP:
5.63
PSA:
56.33
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ADC-1013
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
ADC-1013
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
HM-43239
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
HM-43239
×
Maximum Phase:
1
First Approval:
None
UNII:
C0WUS7XXE9
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DSTA-4637S
1
Unknown
Investigational
Unknown
Unknown
Bacteremia
Unknown
DSTA-4637S
×
Maximum Phase:
1
First Approval:
None
UNII:
BW3SSD8PZ3
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEXANERSEN
1
Oligonucleotide
Investigational
Unknown
Unknown
Huntington Disease
Unknown
LEXANERSEN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
LEMZOPARLIMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma
Unknown
LEMZOPARLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PGT-121
1
Unknown
Investigational
Unknown
Unknown
Acquired Immunodeficiency Syndrome; HIV Infections
Unknown
PGT-121
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4K58C6RT2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CROTEDUMAB
1
Antibody
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Glucagon receptor inhibitor
CROTEDUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
4JQ68PW6XF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NM-21-1480
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
NM-21-1480
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
81
82
83
84
85
86
87
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA